ReviewMolecular & cellular proteomics : MCP2025
Chasing the Ghost Proteome in the Dark Matter.
Review in Molecular & cellular proteomics : MCP, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Microproteins in Human Physiology and Pathology.Biochemistry · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Emerging evidence shows that translation from noncanonical ORFs produces a diverse set of biologically active proteins. These ORFs reside in 5' and 3' UTRs, long noncoding RNAs, overlapping frames within annotated genes (dual coding), or pseudogenes and can initiate at non-AUG start codons. The resulting products, variously termed microproteins, small proteins, small ORF-encoded peptides, and alternative proteins, modulate fundamental cellular processes, including metabolic flux and epigenetic regulation. We consolidate these entities under the umbrella of the ghost proteome, a functional proteome arising from the genome's presumed "dark matter." This concept is distinct from the dark proteome, which refers to regions of canonical proteins lacking structural, functional, or experimental annotation and is not necessarily derived from noncanonical loci. Recognizing the ghost proteome expands the boundary of what is considered protein coding, demands harmonized nomenclature and database integration, and motivates systematic discovery and functional characterization. By reframing sequences once dismissed as noncoding or "junk," the ghost proteome compels a re-evaluation of genome annotation and reveals new opportunities to interrogate biology and disease.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.